The company has demonstrably boosted this development of the novel therapy for amyloid heart disease, employing Attruby. Early patient data indicates significant improvements for those diagnosed with a debilitating https://biotech038417.answerblogs.com/42514981/company-advances-cardiac-amyloidosis-therapy-through-the-drug